Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mora

Showing results (201-210 of 238) with videos related to

Pageof 24
Sort By:
Blood|January 21, 2021
An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trialJudith C Marsh, Simon J Stanworth, Laura A Pankhurst, et al.
European Journal of Neurology|March 12, 2024
European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD)Philip Van Damme, Ammar Al-Chalabi, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trialJesus S Mora, Angela Genge, Adriano Chio, et al.
Scientific Reports|April 13, 2019
Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosisAnnelot M Dekker, Frank P Diekstra, Sara L Pulit, et al.
Human Molecular Genetics|September 24, 2013
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementiaOriol Dols-Icardo, Alberto García-Redondo, Ricard Rojas-García, et al.
Cell Reports|February 28, 2019
Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral SclerosisJohnathan Cooper-Knock, Tobias Moll, Tennore Ramesh, et al.
JAMA Neurology|March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical TrialJeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.
Nature Metabolism|April 28, 2022
Dysregulation of macrophage PEPD in obesity determines adipose tissue fibro-inflammation and insulin resistanceV Pellegrinelli, S Rodriguez-Cuenca, C Rouault, et al.
Annals of Clinical and Translational Neurology|May 22, 2024
Mutations in the tail and rod domains of the neurofilament heavy-chain gene increase the risk of ALSHeather Marriott, Thomas P Spargo, Ahmad Al Khleifat, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALSStacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Pageof 24

Showing results (201-210 of 238) with videos related to

Sort By:
Pageof 24
Blood|January 21, 2021
An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trialJudith C Marsh, Simon J Stanworth, Laura A Pankhurst, et al.
European Journal of Neurology|March 12, 2024
European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD)Philip Van Damme, Ammar Al-Chalabi, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trialJesus S Mora, Angela Genge, Adriano Chio, et al.
Scientific Reports|April 13, 2019
Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosisAnnelot M Dekker, Frank P Diekstra, Sara L Pulit, et al.
Human Molecular Genetics|September 24, 2013
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementiaOriol Dols-Icardo, Alberto García-Redondo, Ricard Rojas-García, et al.
Cell Reports|February 28, 2019
Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral SclerosisJohnathan Cooper-Knock, Tobias Moll, Tennore Ramesh, et al.
JAMA Neurology|March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical TrialJeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.
Nature Metabolism|April 28, 2022
Dysregulation of macrophage PEPD in obesity determines adipose tissue fibro-inflammation and insulin resistanceV Pellegrinelli, S Rodriguez-Cuenca, C Rouault, et al.
Annals of Clinical and Translational Neurology|May 22, 2024
Mutations in the tail and rod domains of the neurofilament heavy-chain gene increase the risk of ALSHeather Marriott, Thomas P Spargo, Ahmad Al Khleifat, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALSStacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Pageof 24